Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics Analysis Identify Novel Microbiome-Metabolome Signatures Associated with Obesity.

Journal of applied microbiology·2026
Same author

Metabolically and epigenetically reprogrammed splenic TRNP1<sup>hi</sup>CD8<sup>+</sup> T cells exacerbate liver fibrosis.

Nature genetics·2026
Same author

Bound polyphenols from carrot dietary fiber delay aging in <i>Caenorhabditis elegans</i> through the IIS pathway and metabolic remodeling.

Food & function·2026
Same author

Cardiovascular Disease Subtypes and Alzheimer's Disease: Phenotypic and Genetic Associations in the UK Biobank and All of Us Research Program.

Journal of the American Heart Association·2026
Same author

Psychosocial predictors of chemotherapy-induced nausea and vomiting among chemotherapy-naïve cancer patients: a prospective multicenter cohort study.

Journal of cancer survivorship : research and practice·2026
Same author

Microwave-Assisted Meta-Chloroperoxybenzoic Acid Epoxidation for Qualitative and Quantitative Analysis of Unsaturated Lipid Double-Bond Positional Isomers by Liquid Chromatography-Tandem Mass Spectrometry.

Journal of separation science·2026

Related Experiment Video

Updated: Jun 26, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans.

Shuang Liang1, Danyang Liu2, Zhengwu Xiao1

  • 1Center for System Biology, Data Sciences, and Reproductive Health, School of Basic Medical Science, Central South University, Changsha 410013, China.

Pharmaceuticals (Basel, Switzerland)
|April 28, 2023
PubMed
Summary

This study identified Vorinostat as a potential drug for sarcopenia, a condition of age-related muscle loss. Further trials are needed, but it shows promise for treating and preventing sarcopenia.

Keywords:
differential analysisdrug repositioninggene set enrichment analysis (GSEA)sarcopeniaweighted correlation network analysis (WGCNA)

More Related Videos

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.0K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
04:23

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

432

Related Experiment Videos

Last Updated: Jun 26, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.0K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
04:23

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

432

Area of Science:

  • Biomedical Science
  • Gerontology
  • Pharmacology

Background:

  • Sarcopenia, the age-related loss of muscle mass and function, presents a significant public health challenge due to the aging global population.
  • Current therapeutic options for sarcopenia are limited, necessitating the urgent identification of effective pharmacological interventions.

Purpose of the Study:

  • To conduct an integrative drug repurposing analysis to identify potential pharmacological treatments for sarcopenia.
  • To validate the efficacy of a top-ranked repurposed drug candidate in vitro.

Main Methods:

  • Utilized transcriptomic sequencing data from human and mouse skeletal muscle.
  • Applied gene differential expression, weighted gene co-expression, and gene set enrichment analyses.
  • Employed gene expression profile similarity, hub gene reversal, pathway enrichment, and rank aggregation for drug identification.

Main Results:

  • Identified Vorinostat as the top-ranking repurposed drug candidate through integrative analysis.
  • Demonstrated Vorinostat's efficacy in promoting muscle fiber formation in an in vitro study.

Conclusions:

  • Vorinostat shows promise as a potential therapeutic agent for sarcopenia treatment and prevention.
  • Further validation in animal models and human clinical trials is warranted to confirm these findings.